NEJM 2026: Corporate Vectors of Chronic Disease

Advancing

In 2026, Dr. Robert Lustig was among the authors of “Corporate Vectors of Chronic Disease — Using Internal Industry Documents to Craft Counterstrategies,” published March 26, 2026 in the New England Journal of Medicine (394(12):1231–1237; doi:10.1056/NEJMms2507028; PMID:41880620). The paper is authored by the “Consortium of the Center to End Corporate Harm, University of California, San Francisco.”

The paper proposes using internal industry documents — the kind of corporate records made public through litigation and disclosures — to craft counterstrategies against health-harming industries. It is the academic complement to the Center to End Corporate Harm’s broader program of mining the UCSF Industry Documents Library, tying Lustig’s food-industry criticism to a formal research and policy agenda.

Timeline

  • March 26, 2026: “Corporate Vectors of Chronic Disease — Using Internal Industry Documents to Craft Counterstrategies” is published in the New England Journal of Medicine (394(12):1231–1237), with Lustig among the consortium authors.

The Weekly Scoreboard

Every Friday: what the RFK Jr. HHS team did this week — wins, setbacks, warnings — sourced and linked. Free.

One email a week. No spam. Unsubscribe anytime. · Follow on Facebook

The Network — One Publisher, Every Front
Published by Bowman Web Services.